← FDA DRUG APPROVALS

FDA NDA · NDA006632

METUBINE IODIDE

Sponsor: LILLY

APPLICATION
NDA006632
TYPE
NDA
ORIGINAL APPROVAL
1949-01-04
LATEST ACTION
2001-09-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METUBINE IODIDEDiscontinued
METOCURINE IODIDE 2MG/ML · INJECTABLE · INJECTION

Approval history

2001-09-17Labeling · Supplement 16 · standardAP
2001-09-17Labeling · Supplement 13AP
1987-07-14Labeling · Supplement 11AP
1981-04-14Labeling · Supplement 6AP
1975-11-03Labeling · Supplement 5AP
1974-07-01Labeling · Supplement 4AP
1949-01-04Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →